Skip to main content
Clinical Trials/EUCTR2015-005222-19-NL
EUCTR2015-005222-19-NL
Active, not recruiting
Phase 1

Effect of neuromuscular blockade and reversal by sugammadex versus neostigmine on breathing when hypoxic or hypercapnic in volunteers - BREATH

eiden University Medical Center0 sitesJuly 13, 2016

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
Postoperative ventilatory control
Sponsor
eiden University Medical Center
Status
Active, not recruiting
Last Updated
9 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
July 13, 2016
End Date
TBD
Last Updated
9 years ago
Study Type
Interventional clinical trial of medicinal product
Sex
All

Investigators

Sponsor
eiden University Medical Center

Eligibility Criteria

Inclusion Criteria

  • Healthy male volunteers aged 18 and older with a body mass index \< 30 kg/m2\.
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1\.2 Adults (18\-64 years) yes
  • F.1\.2\.1 Number of subjects for this age range 36
  • F.1\.3 Elderly (\>\=65 years) no
  • F.1\.3\.1 Number of subjects for this age range

Exclusion Criteria

  • Known or suspected neuromuscular disorders impairing neuromuscular function; allergies to muscle relaxants, anesthetics or narcotics; a (family) history of malignant hyperthermia or any other muscle disease; any medical, neurological or psychiatric illness (including a history of anxiety).

Outcomes

Primary Outcomes

Not specified

Similar Trials